Many biologics, including blockbusters like Epogen/Procrit, are nearing patent expiration, and generics manufacturers, including Sicor (acquired by Teva), Barr Laboratories, and Ivax Corporation, are hoping to market generic biologics.
April 29, 2025
April 16, 2025
March 14, 2025
February 19, 2025
February 10, 2025
February 06, 2025
January 22, 2025